Guizhou Bailing Group Pharmaceutical Co., Ltd. (SZSE:002424) announces a share repurchase program. Under the program, the company will repurchase up to CNY 200 million worth of its A shares. The shares will be repurchased at a price of CNY13.85 per share.

The repurchased shares will be used for employee stock ownership plans or equity incentives. The source of funds for the program is the company's own funds. The program is valid for 6 months.